Marine / Water Treatment
Microbial contamination in water systems is a global problem that spans industries ranging from water treatment plants to shipping. Microbial infections within water treatment plants pose a wide spread health risk to the population and when these infections become biofilm related they can prove exceptionally difficult to remove form tubes, pipes and water vats.
Biofilm formation on the hulls of ships costs shipping industries billions of dollars in extra fuel that is required to combat the increased drag caused by excessive layers of biofilm material. New technologies including altered surface structures and antimicrobial paints help to minimise biofilm attachment.
Perfectus Biomed will test biocides, antimicrobial surfaces, paints and other antimicrobial products in order to investigate their ability to prevent and remove both planktonic and biofilm encased microbial populations.
Our testing experience includes working with:
- Anti-microbial paints
- Anti-fouling products
- Wastewater systems
- Water cooling systems
- Non-sterile manufacturing water systems
We offer a range of test methodologies including:
- Pathogen or specific organisms isolation
- Contaminant identification using API ID strips
- Bioburden assessment
- Total viable bacterial count
- Total viable yeast count
- Total viable mould count
- Environmental monitoring
- ASTM G29-96: Standard practice for determining algal resistance of plastic films
Our library of test organism includes…
Choose from our library of test organism including standard reference strains, clinical isolates and environmental isolates.
Single or mixed species assays containing:
Acinetobacter baumannii, Actinomyces naeslundii, Adenovirus (human), Aspergillus brasiliensis, Aspergillums niger, Aureobasidium pullulans, Bacillus cereus, Bacillus subtilis, Camplylobacter jejuni, Candida albicans, Clostridium difficile, Corynebacterium minutissimum, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium (VRE), Enterococcus hirae, Escherichia coli, Fusobacterium nucleatum, Haemophilus influenzae, Heliocbacter pylori, Halomonas magadiensis, Klebsiella pneumoniae, Lactobacillus casei, MRSA, Neisseria gonorrhoeae, Neisseria subflava, Porphyromonas ginigvalis, Prevotella nigrescens, Propionibacterium acnes, Proteus mirabilis, Pseudomonas aeruginosa, Salmonella enteritidis, Shigella dysenteriae, Staphylococcus aureus (MRSA and MSSA), Staphylococcus epidermidis, Staphylococcus haemolyticus, Stenotrophomonas maltophilia, Streptococcus mutans, Streptococcus oralis, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus zooepidemicus, Tannerella forsythia, Trichophyton rubrum, Veillonella dispar. WHO Priority organisms. Other- please ask.
- Christmas Opening Hours
- Regulatory Focus; Medical Device Regulations
- World Health Organisation publishes list of bacteria for which new antibiotics are needed
- Perfectus Biomed shortlisted for the Mornflake Oats Award for Innovation and the Outstanding Cheshire & Warrington Business Leader Award
- FDA to improve the review of shared Risk Evaluation and Mitigation Strategies to enhance generic drug access
- The National Biofilms Innovation Centre (NBIC) Launch Event
- Perfectus Biomed Website Redesign
- EPA protects health care facilities from unregistered antimicrobial pesticides
- Living Wage Week
- Pharmig’s 25th Celebratory Conference 2017